Holdings of Fidelity Disruptive Medicine ETF
Fidelity Covington Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 60.9M $ including 60.5M $ in equities, 99.3 %
- Positions
- 66 in 11 countries
- Top ten
- 34.6 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Danaher Corp | 12,280 | 2.6M $ | 4.24 % |
| 2 | UCB SA | 8,299 | 2.5M $ | 4.06 % |
| 3 | Boston Scientific Corp | 32,000 | 2.5M $ | 4.04 % |
| 4 | Argenx SE | 3,053 | 2.3M $ | 3.84 % |
| 5 | Cogent Biosciences Inc | 60,000 | 2.3M $ | 3.83 % |
| 6 | Alnylam Pharmaceuticals Inc | 6,060 | 2M $ | 3.31 % |
| 7 | Intuitive Surgical Inc | 3,800 | 1.9M $ | 3.14 % |
| 8 | Veeva Systems Inc | 10,000 | 1.8M $ | 2.99 % |
| 9 | Insulet Corp | 6,372 | 1.6M $ | 2.58 % |
| 10 | Moderna Inc | 29,259 | 1.6M $ | 2.57 % |
| 11 | Waystar Holding Corp | 60,000 | 1.5M $ | 2.53 % |
| 12 | Edwards Lifesciences Corp | 17,421 | 1.5M $ | 2.47 % |
| 13 | LifeStance Health Group Inc | 206,792 | 1.5M $ | 2.46 % |
| 14 | Vaxcyte Inc | 22,513 | 1.4M $ | 2.28 % |
| 15 | Insmed Inc | 8,000 | 1.2M $ | 1.96 % |
| 16 | Sartorius Stedim Biotech | 5,513 | 1.2M $ | 1.96 % |
| 17 | Stryker Corp | 2,925 | 1.1M $ | 1.86 % |
| 18 | Eli Lilly & Co | 1,030 | 1.1M $ | 1.78 % |
| 19 | Privia Health Group Inc | 45,000 | 1.1M $ | 1.75 % |
| 20 | Thermo Fisher Scientific Inc | 2,036 | 1.1M $ | 1.74 % |
| 21 | LEGEND BIOTECH CORP | 55,400 | 1.1M $ | 1.73 % |
| 22 | 10X Genomics Inc | 45,000 | 1M $ | 1.70 % |
| 23 | Penumbra Inc | 3,000 | 1M $ | 1.70 % |
| 24 | Kymera Therapeutics Inc | 10,000 | 913.5K $ | 1.50 % |
| 25 | Stoke Therapeutics Inc | 25,079 | 913.1K $ | 1.50 % |
| 26 | Ascendis Pharma A/S | 3,865 | 902.5K $ | 1.48 % |
| 27 | UnitedHealth Group Inc | 2,973 | 871.9K $ | 1.43 % |
| 28 | Natera Inc | 4,179 | 869.4K $ | 1.43 % |
| 29 | Lonza Group AG | 1,242 | 866.2K $ | 1.42 % |
| 30 | Cytokinetics Inc | 13,223 | 822.7K $ | 1.35 % |
| 31 | Caris Life Sciences Inc | 40,000 | 805.6K $ | 1.32 % |
| 32 | Crinetics Pharmaceuticals Inc | 19,000 | 780.9K $ | 1.28 % |
| 33 | Dexcom Inc | 10,449 | 767.3K $ | 1.26 % |
| 34 | Disc Medicine Inc | 11,078 | 738K $ | 1.21 % |
| 35 | Veracyte Inc | 20,000 | 731.8K $ | 1.20 % |
| 36 | ResMed Inc | 2,800 | 717.5K $ | 1.18 % |
| 37 | Xenon Pharmaceuticals Inc | 15,658 | 676.9K $ | 1.11 % |
| 38 | CENTESSA PHARMACEUTICALS PLC | 22,800 | 612.4K $ | 1.01 % |
| 39 | Nuvalent Inc | 6,000 | 611.7K $ | 1.00 % |
| 40 | CytomX Therapeutics Inc | 112,069 | 601.8K $ | 0.99 % |
| 41 | Alignment Healthcare Inc | 30,094 | 578.4K $ | 0.95 % |
| 42 | Align Technology Inc | 2,979 | 566.3K $ | 0.93 % |
| 43 | Guardant Health Inc | 6,000 | 563.4K $ | 0.92 % |
| 44 | WaVe Life Sciences Ltd | 40,000 | 557.2K $ | 0.91 % |
| 45 | Kiniksa Pharmaceuticals International Plc | 12,000 | 533.9K $ | 0.88 % |
| 46 | Roivant Sciences Ltd | 18,000 | 520.9K $ | 0.85 % |
| 47 | Repligen Corp | 3,970 | 511.1K $ | 0.84 % |
| 48 | Enliven Therapeutics Inc | 17,123 | 508.4K $ | 0.83 % |
| 49 | Bio-Techne Corp | 8,359 | 493.2K $ | 0.81 % |
| 50 | ZAI LAB LTD | 24,439 | 469.7K $ | 0.77 % |
| 51 | Structure Therapeutics Inc | 7,402 | 466.2K $ | 0.77 % |
| 52 | Viking Therapeutics Inc | 13,375 | 452.6K $ | 0.74 % |
| 53 | Olema Pharmaceuticals Inc | 18,000 | 435.6K $ | 0.71 % |
| 54 | Kestra Medical Technologies Ltd | 18,400 | 428.4K $ | 0.70 % |
| 55 | IRhythm Holdings Inc | 3,155 | 422K $ | 0.69 % |
| 56 | Doximity Inc | 16,000 | 392.5K $ | 0.64 % |
| 57 | Newamsterdam Pharma Co NV | 10,794 | 382.8K $ | 0.63 % |
| 58 | Amylyx Pharmaceuticals Inc | 23,554 | 357.3K $ | 0.59 % |
| 59 | Mirum Pharmaceuticals Inc | 3,500 | 323K $ | 0.53 % |
| 60 | ZENAS BIOPHARMA INC | 10,000 | 263.5K $ | 0.43 % |
| 61 | Janux Therapeutics Inc | 18,809 | 256K $ | 0.42 % |
| 62 | BioNTech SE | 2,296 | 253.1K $ | 0.42 % |
| 63 | PROCEPT BIOROBOTICS CORP | 10,651 | 241.7K $ | 0.40 % |
| 64 | Soleno Therapeutics Inc | 6,105 | 238.5K $ | 0.39 % |
| 65 | Upstream Bio Inc | 16,000 | 122.9K $ | 0.20 % |
| 66 | Outset Medical Inc | 34,000 | 118.7K $ | 0.19 % |
Sector breakdown
- Health care 40.6 %
- Technology 3.0 %
- Unattributed 56.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 92.5 %
- EUR 6.1 %
- CHF 1.4 %
The quoted currency of each line, as declared.
Country breakdown
- United States 80.0 %
- Netherlands 4.5 %
- Belgium 4.1 %
- Cayman Islands 2.5 %
- France 2.0 %
- Bermuda 1.6 %
- Denmark 1.5 %
- Switzerland 1.4 %
- Canada 1.1 %
- Singapore 0.9 %
- Germany 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 53 | 48.4M $ | 79.98 % |
| 2 | Netherlands | 2 | 2.7M $ | 4.50 % |
| 3 | Belgium | 1 | 2.5M $ | 4.09 % |
| 4 | Cayman Islands | 2 | 1.5M $ | 2.51 % |
| 5 | France | 1 | 1.2M $ | 1.97 % |
| 6 | Bermuda | 2 | 949.3K $ | 1.57 % |
| 7 | Denmark | 1 | 902.5K $ | 1.49 % |
| 8 | Switzerland | 1 | 866.2K $ | 1.43 % |
| 9 | Canada | 1 | 676.9K $ | 1.12 % |
| 10 | Singapore | 1 | 557.2K $ | 0.92 % |
| 11 | Germany | 1 | 253.1K $ | 0.42 % |
Cite this page
Titelia. "Holdings of Fidelity Disruptive Medicine ETF". https://titelia.com/en/funds/S000079688